UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047217
Receipt number R000033708
Scientific Title Effectiveness of a cognitive behavioural therapy-based anxiety prevention education program for elementary and junior high school students
Date of disclosure of the study information 2022/03/18
Last modified on 2024/11/13 09:50:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of a cognitive behavioural therapy-based anxiety prevention education program for elementary and junior high school students

Acronym

Effectiveness of CBT-based anxiety prevention program

Scientific Title

Effectiveness of a cognitive behavioural therapy-based anxiety prevention education program for elementary and junior high school students

Scientific Title:Acronym

Effectiveness of CBT-based anxiety prevention program

Region

Japan


Condition

Condition

Elementary school children aged 10-12
Junior high school children aged 13-15
Parents
Teachers

Classification by specialty

Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate changes in children and teacher's anxiety scores before and after a cognitive-behavioral program implemented at school

Basic objectives2

Others

Basic objectives -Others

To evaluate the effectiveness of the intervention by comparing the intervention and control groups.

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Spence Children's Anxiety Scale: SCAS for children and parents
(pre, post, 3 months follow-up)

Key secondary outcomes

Emotion-Regulation Skills Questionnaire: ERSQ (pre, post, 3 months follow-up)
Strength and Difficulties Questionnaire: SDQ (pre, post, 3 months follow-up)
PHQ-9 (pre, post)
GAD-7 (pre, post)
Psychological safty scale for workers (pre, post)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

The Journey of the Brave
Cognitive behavioral therapy based anxiety prevention education program

Interventions/Control_2

Regular classes

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

children attending the elementary school in grade 4-6 or the junior high school in grade 1-3 and their parents, teachers

Key exclusion criteria

children not attending school and their parents

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Shimizu

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

260-8670

Address

1-8-1 Inohana, Chuouku, Chiba, Japan

TEL

043-226-2975

Email

eiji@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Yuko
Middle name
Last name Urao

Organization

Chiba University

Division name

Research Center for Child Mental Development

Zip code

260-8670

Address

1-8-1 Inohana, Chuouku, Chiba, Japan

TEL

043-226-2975

Homepage URL


Email

yurao@faculty.chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University School of Medicine Ethics Committee

Address

1-8-1 Inohana, Chuouku, Chiba, Japan

Tel

043-226-2501

Email

igaku-rinri@office.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 06 Month 01 Day

Date of IRB

2017 Year 06 Month 05 Day

Anticipated trial start date

2017 Year 07 Month 20 Day

Last follow-up date

2027 Year 07 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2022 Year 03 Month 18 Day

Last modified on

2024 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033708